NCT05867316

Brief Summary

Suicide is among the leading causes of death worldwide, and the risk of suicide is highest in the period immediately following discharge from inpatient psychiatric care.1Importantly, despite the enormously elevated risk during this period, nearly 50% of patients do not attend scheduled therapy after discharge. Even among those who do attend therapy, however, the skills learned in treatment may be difficult to use during the highly distressing time leading up to and during a suicide crisis. Most traditional treatments are not designed to be effective during a suicide crisis. In order to reduce the risk of suicidal thoughts and behaviors in general and specifically during the post-discharge period, interventions are needed that: (1) are easily adhered to and (2) are accessible and effective during a suicide crisis. As such, the purpose of this research study is to test an innovative, new intervention in order to develop an effective and accessible intervention for those at high risk for suicide

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 19, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 14, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2024

Completed
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

8 months

First QC Date

April 3, 2023

Last Update Submit

June 10, 2025

Conditions

Keywords

suicidal ideationsuicide attempts

Outcome Measures

Primary Outcomes (2)

  • Suicidal thoughts

    Within-person changes in momentary self-reported intensity of suicidal urges (measured on a 11-point rating scale via ecological momentary assessment) from pre- to post-EMI

    Overall changes in momentary self-reported intensity of suicidal urges (on a 11-point scale up to 4x/ day via ecological momentary assessment) from pre- to post-EMI use, across the study period, which is approximately four weeks post discharge

  • Self-efficacy for managing negative emotion

    Measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) self-efficacy for managing negative emotions scale. The scale is measured with four five-point scale items, summed to a score ranging from 4 to 20 where higher scores are better.

    Beginning of study and end-of-study, approximately four weeks post discharge

Study Arms (1)

Unified Protocol

EXPERIMENTAL

Unified Protocol-based treatment, with three sessions

Behavioral: Unified Protocol

Interventions

Unified Protocol based treatment, modified for use in brief treatment on inpatient units

Unified Protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult status (18+ years)
  • Admission to eligible units in our partner hospital with a reason for admission having to do with suicide risk
  • The ability to speak and write English fluently,
  • Ownership of and consistent access to an internet-capable smartphone (e.g., an iPhone or Android phone)

You may not qualify if:

  • \- The presence of any factor that impairs an individual's ability to provide informed consent and comprehend and effectively participate in the study including: an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers University Behavioral Healthcare

Piscataway, New Jersey, 08854, United States

Location

MeSH Terms

Conditions

SuicideSelf-Injurious BehaviorEmotional RegulationSuicidal IdeationSuicide, Attempted

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSelf-ControlSocial Behavior

Study Officials

  • Evan Kleiman

    Rutgers, The State University of New Jersey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 3, 2023

First Posted

May 19, 2023

Study Start

September 14, 2023

Primary Completion

May 7, 2024

Study Completion

June 6, 2024

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

We will share Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices)

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Code will be shared within three months after manuscript publication.
More information

Locations